\-\ Texto\\:\\ \ \(0\)\
\-\ not\\ available\ \(73\)\
\-\ supportive\ \(54\)\
\-\ abnormal\\ enhancement\\ and\\ mild\\ enlargement\\ of\\ the\\ cisternal\\ portion\ \(0\)\
\-\ of\\ the\\ left\\ trigeminal\\ nerve\\.\ \(0\)\
\-\ radiation\\ neuritis\\ trigeminal\\ nerve\\ secondary\\ to\\ gamma\\ knife\\ therapy\\.\ \(0\)\
\-\ \\â\\€\\¢\\ meningioma\ \(7\)\
\-\ \\â\\€\\¢\\ schwannoma\ \(0\)\
\-\ \\â\\€\\¢\\ metastatic\\ disease\ \(13\)\
\-\ \\â\\€\\¢\\ trigeminal\\ neuritis\ \(0\)\
\-\ 61\\ year\\ old\\ man\\,\\ presents\\ with\\ recurrent\\ left\\ facial\\ pain\\.\ \(1\)\
\-\ pmhx\\ \\-\\ 15\\ months\\ ago\\,\\ he\\ had\\ gamma\\ knife\\ therapy\\ for\\ left\\ tic\\ doloreux\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ trigeminal\\:\\ 0\\.2431719327803078\ \(0\)\
\-\ neuritis\\:\\ 0\\.16407033461528311\ \(0\)\
\-\ knife\\:\\ 0\\.16307670362064702\ \(0\)\
\-\ gamma\\:\\ 0\\.15690703831030645\ \(0\)\
\-\ tic\\:\\ 0\\.13356846096918937\ \(0\)\
\-\ doloreux\\:\\ 0\\.13356846096918937\ \(0\)\
\-\ cisternal\\:\\ 0\\.10027717949439816\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.09497056676338715\ \(0\)\
\-\ nerve\\:\\ 0\\.09330139777234261\ \(0\)\
\-\ pmhx\\:\\ 0\\.07658058042837781\ \(0\)\
\-\ 61\\:\\ 0\\.07623225439467025\ \(0\)\
\-\ therapy\\:\\ 0\\.06923153928001857\ \(0\)\
\-\ schwannoma\\:\\ 0\\.059134296033794644\ \(0\)\
\-\ supportive\\:\\ 0\\.057250997296255594\ \(0\)\
\-\ facial\\:\\ 0\\.05629775751730757\ \(0\)\
\-\ recurrent\\:\\ 0\\.0546368525928042\ \(0\)\
\-\ 15\\:\\ 0\\.05164161594706636\ \(0\)\
\-\ enlargement\\:\\ 0\\.05137224858310751\ \(0\)\
\-\ meningioma\\:\\ 0\\.04978923237053144\ \(0\)\
\-\ ago\\:\\ 0\\.048192860921170436\ \(0\)\
\-\ portion\\:\\ 0\\.046897070414531616\ \(0\)\
\-\ available\\:\\ 0\\.04352604619454238\ \(0\)\
\-\ left\\:\\ 0\\.04345933042149613\ \(0\)\
\-\ radiation\\:\\ 0\\.04248865529639904\ \(0\)\
\-\ abnormal\\:\\ 0\\.03692564000477139\ \(0\)\
\-\ secondary\\:\\ 0\\.036197423734981936\ \(0\)\
\-\ he\\:\\ 0\\.036124050636863934\ \(0\)\
\-\ months\\:\\ 0\\.03536274688924344\ \(0\)\
\-\ enhancement\\:\\ 0\\.034704375244288425\ \(0\)\
\-\ mild\\:\\ 0\\.03409474930198692\ \(0\)\
\-\ metastatic\\:\\ 0\\.03259256672145591\ \(0\)\
\-\ man\\:\\ 0\\.030620179440757563\ \(0\)\
\-\ had\\:\\ 0\\.027937118473344066\ \(0\)\
\-\ \\-\\:\\ 0\\.027753461495581267\ \(0\)\
\-\ presents\\:\\ 0\\.026449155992544333\ \(0\)\
\-\ disease\\:\\ 0\\.02116269001841976\ \(0\)\
\-\ not\\:\\ 0\\.01870937381427175\ \(0\)\
\-\ pain\\:\\ 0\\.01581224496258689\ \(0\)\
\-\ year\\:\\ 0\\.014486443473832041\ \(0\)\
\-\ old\\:\\ 0\\.013256584800943253\ \(0\)\
\-\ for\\:\\ 0\\.01104709316125326\ \(0\)\
\-\ \\,\\:\\ 0\\.008203335318705679\ \(0\)\
\-\ to\\:\\ 0\\.006470728915802823\ \(0\)\
\-\ the\\:\\ 0\\.004189372263746236\ \(0\)\
\-\ of\\:\\ 0\\.0035304182059996496\ \(0\)\
\-\ and\\:\\ 0\\.0027274091777608855\ \(0\)\
\-\ \\.\\:\\ 0\\.0021514870362028047\ \(0\)\
\-\ with\\:\\ 0\\.0017727905468165111\ \(0\)\
